PharmLytix provides AI-powered recommendations based on medication lists. We’re a standalone platform that is cost effective and does not require an EHR integration. Designed by consultant pharmacists for consultant pharmacists serving assisted living, skilled nursing, and senior care communities.
AI-Powered Consultant Pharmacist Software Built for Long-Term Care
No EHR Integrations Required with PharmLytix
Unlike traditional platforms, PharmLytix does not require complicated integrations with electronic health records or pharmacy systems.
How It Works
Upload medication administration records (MARs)
Let PharmLytix do the work. PharmLytix extracts and structures the data automatically using AI
Consultant pharmacists receive streamlined review workflows and reporting tools.
Simple. Fast. Scalable.
Traditional consultant pharmacist software is outdated, inefficient, and heavily dependent on expensive integrations and manual workflows.
Many pharmacists today struggle with:
- Time-consuming medication reviews
- Limited clinical decision support
- Fragmented reporting processes
- Poor workflow efficiency
- Manual data entry
- Complex implementation requirements
- Limited visibility into community-wide medication trends
PharmLytix was built to solve these problems using modern AI technology designed specifically for long-term care consulting pharmacists.
AI-Powered Clinical Decision Support
PharmLytix helps consultant pharmacists identify medication irregularities, potential risks, therapeutic opportunities, and monitoring considerations faster and more efficiently.
- Duplicate therapy identification
- Drug-drug interaction analysis
- High-risk medication monitoring
- Psychotropic medication oversight
- Renal dosing considerations
- Anticholinergic burden review
- Fall-risk medication analysis
- Deprescribing opportunities
- Monitoring recommendations
AI Recommendations
Medication Irregularity
Omeprazole Oral Capsule Delayed Release 20 MG
Drug Irregularity
Consider a trial reduction to Omeprazole 10 MG once daily as no medication is on board to warrant long term therapy.
Recommended Course of Action
Assess if a reduction might be appropriate.
Recommendation Type
Nurse
Provider
Timeframe to Address
ASAP – Within 24 Hours
ASAP – Within 60 Days
Next Provider Rounds
RN to Assess
MRR/IMR/PMR
MRR
IMR
PMR
Category
Reduce
Intelligent Medication Review Workflow
Designed to reduce administrative burden while improving review consistency and documentation quality.
Features include:
- Streamlined medication review workflows
- Community-wide review management
- Review tracking and organization
- Centralized documentation
- Efficient monthly consultant review processes
Patient MRR
*GDR is set to: DULoxetine HCL Oral Capsule Delayed Release Particles 60 MG (Duloxetine HCI): 12-15-2026
First Name
John
Last Name
Doe
DOB
11-09-1945
MRN
004321
Medication
Diagnosis
Dose
Add Rec
Donepezil HCl Oral Tablet 10 MG (Donepezil Hydrochloride)
UNSPECIFIED INTELLECTUAL DISABILITIES (F79)
Give 1 tablet by mouth at bedtime
lamoTRIgine Oral Tablet 200 MG (Lamotrigine)
INTERMITTENT EXPLOSIVE DISORDER (F63.81)
Give 1 tablet by mouth in the afternoon
Remeron Oral Tablet (Mirtazapine)
GENERALIZED ANXIETY DISORDER (F41.1)
Give 15 mg by mouth in the evening
CMR Documentation & Reporting
PharmLytix can also function as a centralized platform for Comprehensive Medication Reviews (CMRs).
The platform enables:
- CMR recording and documentation
- Standardized pharmacist recommendations
- Reporting and tracking capabilities
- Historical review retention
- Operational oversight and quality tracking
GDR Patient Details
Patient
Medication
GDR Date
Status
John Doe
Ozempic (0.25 or 0.5 MG/DOSE) Subcutaneous Solution Pen-injector 2 MG/3ML (Semaglutide)
5-12-2026
In Progress: AI-Enhanced Reporting
Generate meaningful reports that facilities and pharmacists actually need.
Examples include:
- Medication utilization trends
- Psychotropic monitoring reports
- High-risk medication summaries
- Consultant pharmacist intervention tracking
- Community medication analytics
- Regulatory support documentation
- Quality assurance reporting
Run Report
Run QA Reports
Run MRR Reports
Run CMR Reports
Run IMR Reports
Run PMR Reports
Run Psych Reports
No Recommendations
Aggregated Recommendations
Run By Unit/Station
All units/stations
Provider
All Providers
Recommendation Type
All recommendation types
Start Month & Year
——— —-
End Month & Year
——— —-
Continuous AI Innovation
PharmLytix is designed with AI at its core.
As artificial intelligence capabilities continue to evolve, PharmLytix will continue integrating advanced AI-driven workflow automation, recommendation support, reporting intelligence, and efficiency enhancements directly into the platform.
Our goal is simple:
Help consultant pharmacists work smarter, faster, and more effectively.
Why PharmLytix?
Save Time
Reduce manual review workload and administrative burden.
Improve Efficiency
Streamline consultant pharmacist workflows across communities.
Better Clinical Oversight
Receive intelligent AI-powered decision support during reviews.
No Integrations Needed
Start quickly without lengthy IT implementation projects.
Scalable Workflow
Designed for individual pharmacists, consultant groups, and organizations.
Future-Focused Platform
Built on modern AI architecture designed to continually evolve.
Everything you need to know
Does PharmLytix require EHR integrations?
No. PharmLytix works through MAR uploads and AI-powered extraction.
What types of communities can use PharmLytix?
Assisted living, skilled nursing, and long-term care organizations.
What makes PharmLytix different?
PharmLytix is one of the first AI-powered consultant pharmacist workflow platforms designed specifically for long-term care consulting.
Can PharmLytix support CMR documentation?
Yes. The platform supports recording, tracking, and reporting on comprehensive medication reviews.
Got a question? No problem.
Streamline medication reviews, improve clinical decision support, and generate actionable reporting — all without complex integrations.
Become an Early Adopter
Join the first wave of consultant pharmacists adopting AI-powered medication review technology.
Included Benefits
- Introductory pricing locked in at $60/user/month
- Early access to new AI features
- Opportunity to provide platform feedback
- Influence future development priorities
- Priority onboarding and support
Fill out our contact form to request early access.
PharmLytix
Ready to Modernize Medication Reviews?